Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
Clicks: 321
ID: 13030
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
71.0
/100
313 views
255 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract Extracellular vesicles (EVs) are small, lipid-bound particles containing nucleic acid and protein cargo which are excreted from cells under a variety of normal and pathological conditions. EVs have garnered substantial research interest in recent years, due to their potential utility as circulating biomarkers for a variety of diseases, including numerous types of cancer. The following review will discuss the current understanding of the form and function of EVs, their specific role in cancer pathogenesis and their potential for non-invasive disease diagnosis and/or monitoring. This review will also highlight several key issues for this field, including the importance of implementing robust and reproducible sample handling protocols, and the challenge of extracting an EV-specific biomarker signal from a complex biological background.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (121 words).
Try re-searching for a better abstract.
| Reference Key |
lane2018extracellularclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lane, R. E.;Korbie, D.;Hill, M. M.;Trau, M.; |
| Journal | clinical and translational medicine |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.